Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126


Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study.

Domschke C, Diel IJ, Englert S, Kalteisen S, Mayer L, Rom J, Heil J, Sohn C, Schuetz F.

Ann Surg Oncol. 2013 Jun;20(6):1865-71. doi: 10.1245/s10434-012-2814-4.


Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.

Solá M, Margelí M, Castellá E, Cirauqui B, Mariscal A, Rull M, Julian JF, Luna M, Vallejo V, Fraile M.

Breast. 2013 Oct;22(5):908-13. doi: 10.1016/j.breast.2013.04.014.


Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G.

J Natl Cancer Inst. 1996 Nov 20;88(22):1652-8.


Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.

Schindlbeck C, Andergassen U, Hofmann S, Jückstock J, Jeschke U, Sommer H, Friese K, Janni W, Rack B.

J Cancer Res Clin Oncol. 2013 Jun;139(6):1055-62. doi: 10.1007/s00432-013-1418-0.


Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.

Bidard FC, Vincent-Salomon A, Gomme S, Nos C, de Rycke Y, Thiery JP, Sigal-Zafrani B, Mignot L, Sastre-Garau X, Pierga JY; Institut Curie Breast Cancer Study Group..

Clin Cancer Res. 2008 Jun 1;14(11):3306-11. doi: 10.1158/1078-0432.CCR-07-4749.


Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.

Hartkopf AD, Taran FA, Wallwiener M, Hahn M, Becker S, Solomayer EF, Brucker SY, Fehm TN, Wallwiener D.

Eur J Cancer. 2014 Oct;50(15):2550-9. doi: 10.1016/j.ejca.2014.06.025.


The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse.

Hartkopf AD, Banys M, Meier-Stiegen F, Hahn M, Röhm C, Hoffmann J, Helms G, Taran FA, Wallwiener M, Walter C, Neubauer H, Wallwiener D, Fehm T.

Breast Cancer Res Treat. 2013 Apr;138(2):509-17. doi: 10.1007/s10549-013-2470-9.


Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.

Falck AK, Bendahl PO, Ingvar C, Isola J, Jönsson PE, Lindblom P, Lövgren K, Rennstam K, Fernö M, Rydén L.

BMC Cancer. 2012 Sep 11;12:403. doi: 10.1186/1471-2407-12-403.


Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.

Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, Rodrigues M, Diéras V, Mignot L, Sastre-Garau X, Poupon MF, Pierga JY.

Clin Exp Metastasis. 2008;25(8):871-5. doi: 10.1007/s10585-008-9203-1.


Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.

Banys M, Solomayer EF, Gebauer G, Janni W, Krawczyk N, Lueck HJ, Becker S, Huober J, Kraemer B, Wackwitz B, Hirnle P, Wallwiener D, Fehm T.

BMC Cancer. 2013 Oct 15;13:480. doi: 10.1186/1471-2407-13-480.


Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study.

Solá M, Margelí M, Castellá E, Julian JF, Rull M, Gubern JM, Mariscal A, Barnadas A, Fraile M.

BMC Cancer. 2011 Jun 16;11:252. doi: 10.1186/1471-2407-11-252.


Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.

Schwarzenbach H, Pantel K, Kemper B, Beeger C, Otterbach F, Kimmig R, Kasimir-Bauer S.

Breast Cancer Res. 2009;11(5):R71. doi: 10.1186/bcr2404.


Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse.

Hartkopf AD, Wallwiener M, Fehm TN, Hahn M, Walter CB, Gruber I, Brucker SY, Taran FA.

Ann Oncol. 2015 Jun;26(6):1155-60. doi: 10.1093/annonc/mdv148.


The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.

Wu P, Tang RN, Zou JH, Wang FC.

Hepatogastroenterology. 2012 Oct;59(119):2164-7. doi: 10.5754/hge12539.


Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer.

Gruber I, Fehm T, Taran FA, Wallwiener M, Hahn M, Wallwiener D, Krawzyck N, Hoffmann J, Hartkopf AD.

Breast Cancer Res Treat. 2014 Apr;144(2):353-60. doi: 10.1007/s10549-014-2853-6.


Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.

Tjensvoll K, Oltedal S, Heikkilä R, Kvaløy JT, Gilje B, Reuben JM, Smaaland R, Nordgård O.

BMC Cancer. 2012 May 28;12:190. doi: 10.1186/1471-2407-12-190.


Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer.

Bidard FC, Kirova YM, Vincent-Salomon A, Alran S, de Rycke Y, Sigal-Zafrani B, Sastre-Garau X, Mignot L, Fourquet A, Pierga JY.

Ann Oncol. 2009 Nov;20(11):1836-41. doi: 10.1093/annonc/mdp200.


Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.

Hinz S, Bockhorst J, Röder C, Egberts JH, Schafmayer C, Küchler T, Becker T, Kalthoff H.

Ann Surg Oncol. 2012 Aug;19(8):2539-46. doi: 10.1245/s10434-012-2291-9.


Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients.

Krawczyk N, Hartkopf A, Banys M, Meier-Stiegen F, Staebler A, Wallwiener M, Röhm C, Hoffmann J, Hahn M, Fehm T.

BMC Cancer. 2014 Jun 3;14:394. doi: 10.1186/1471-2407-14-394.


Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.

Gilje B, Nordgård O, Tjensvoll K, Janssen EA, Søiland H, Smaaland R, Baak JP.

Breast Cancer Res Treat. 2011 Jul;128(1):137-46. doi: 10.1007/s10549-011-1487-1.

Items per page

Supplemental Content

Support Center